血管遗传因素在妊娠前中的作用
Angeliki Papapanagiotou1, Maria Anastasia Daskalaki2, Antonios N Gargalionis3
1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
International journal of molecular sciences
|November 13, 2025
概括
sFlt-1/PlGF比率有助于预测和诊断早期妊娠前 (PE). 这种生物标志物可以改善临床管理,减少住院治疗,降低高风险妊娠的医疗费用.
科学领域:
- 产科和妇科 产科和妇科
- 孕产妇和胎儿医学 孕产妇和胎儿医学
- 生物标志物研究 生物标志物研究
背景情况:
- 孕前 (PE) 是孕产妇和胎儿死亡的主要原因之一.
- 缺陷的胎盘导致血管生成因子的不平衡,这是PE病原体的核心.
- 可溶性fms类氨酸激酶-1 (sFlt-1) 中和血管性因素,破坏正常信号传输.
研究的目的:
- 审查sFlt-1/PlGF比率在PE预测,诊断和管理中的临床实用性.
- 为了强调实施sFlt-1/PlGF比率测试的成本效益.
- 突出高风险怀孕中sFlt-1/PlGF比率的预后潜力.
主要方法:
- 对近期关于sFlt-1/PlGF比率在孕前方面的研究进行了综述.
- 分析比率在确认和排除PE时的作用.
- 评估该比率对临床决策和医疗保健成本的影响.
主要成果:
- sFlt-1/PlGF比率显示了早期PE风险识别的预测价值.
- 该比率在高风险人群中有效证实和排除PE.
- 实施sFlt-1/PlGF比率测量可以减少不必要的住院和早产.
结论:
- sFlt-1/PlGF比率是早期检测和治疗妊娠前的一个有价值的工具.
- 常规使用sFlt-1/PlGF比率可以优化患者护理并降低医疗保健支出.
- 这种生物标志物支持基于证据的临床决策,改善PE风险女性的结果.
更多相关视频
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
1.2K
09:03Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
1.6K
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:33Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K
01:10Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
01:07Development of Blood Vessels
1.3K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.3K
01:29Hypertension II: Pathophysiology
765
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
765
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K